Literature DB >> 3198352

Comparative chemical structure and pharmacokinetics of MRI contrast agents.

M F Tweedle1, S M Eaton, W C Eckelman, G T Gaughan, J J Hagan, P W Wedeking, F J Yost.   

Abstract

The blood clearance kinetics of five gadolinium complexes, Gd(L), were determined in rats and the results interpreted in terms of an open two-compartment pharmacokinetic model. The complexes were tested in vitro for stability in serum and in aqueous solutions of ions that they might encounter in vivo and that might be expected to react with the Gd(L) complexes to produce uncomplexed gadolinium. Reaction with serum was observed in two instances. Chemical structural differences among the chelating ligands appear to govern the overall reactivity of their Gd(L) complexes. It may be inferred from the results that a preferred structural feature of the ligand is the presence of a 12-membered 1,4,7,10-tetraaza macrocycle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198352     DOI: 10.1097/00004424-198809001-00049

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

1.  Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.

Authors:  M Meser Ali; Byunghee Yoo; Mark D Pagel
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 2.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

Review 3.  New magnetic resonance imaging techniques for the detection of breast cancer.

Authors:  K Orang-Khadivi; B L Pierce; C M Ollom; L J Floyd; R L Siegle; R F Williams
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 4.  Currently used non-specific extracellular MR contrast media.

Authors:  M F Bellin; M Vasile; S Morel-Precetti
Journal:  Eur Radiol       Date:  2003-06-19       Impact factor: 5.315

5.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

6.  Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.

Authors:  P Akeson; E Jonsson; I Haugen; S Holtås
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.